Product
ASKG712
Aliases
AM712
2 clinical trials
2 indications
Indication
Age-Related Macular DegenerationIndication
Diabetic Macular EdemaClinical trial
A Multi-Center, Open-label, Single Ascending-Dose and Multiple Ascending-Dose Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ASKG712 Following Intravitreal Administration in Patients With Neovascular Age-related Macular DegenerationStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
A Multicenter, Non-Randomized, Open-Label, Multiple-Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of ASKG712 Following Intravitreal Administration in Patients With Diabetic Macular EdemaStatus: Not yet recruiting, Estimated PCD: 2024-12-31